Angiotensin-converting enzyme 2 (ACE2) has been identified as a biomarker and a promising therapeutic target in several diseases. The noninvasive visualization of in vivo ACE2 mapping is urgent for disease guidance and treatment assessment. A radioimmuno assay... ...

请注册登录后继续浏览